| Literature DB >> 27693631 |
Qiulian Li1, Chao Zhang2, Ruichao Chen3, Hanzhen Xiong3, Fuman Qiu3, Shaoyan Liu3, Minfen Zhang3, Fang Wang4, Yu Wang2, Xuan Zhou5, Guohong Xiao6, Xudong Wang7, Qingping Jiang8.
Abstract
Endometrioid endometrial carcinoma (EEC) is the most common gynecologic malignancy around the world. Epithelial-to-mesenchymal transition (EMT) is a core process during EEC cell invasion. The abnormal expression of the long noncoding RNA metastasis associated lung adenocarcinoma transcript 1 (MALAT1) or miR-200 family members were shown to facilitate EMT in multiple human cancers, but the regulatory mechanism by which MALAT1 and miR-200 act remains unknown. Previous studies have shown that miR-200 family members are enriched in EEC as well as melanoma and some ovarian carcinomas. In the present study, we first showed that miR-200c levels were higher in most EEC specimens than in non-tumor tissues, while MALAT1 levels were lower. Moreover, we found that miR-200c bound directly to MALAT1 using luciferase reporter and qRT-PCR assays. MALAT1 and miR-200c are reciprocally repressed, and TGF-β increased MALAT1 expression by inhibiting miR-200c. When the interaction between miR-200c/MALAT1 was interrupted, the invasive capacity of EEC cells was decreased and EMT markers expression were altered in vitro. A xenograft tumor model was used to show that targeting the miR-200c/MALAT1 axis inhibited EEC growth and EMT-associated protein expression in vivo. In summary, miR-200c/MALAT1 axis is a target with therapeutic potential in EEC. However, different expression model of miR-200c and MALAT1 in EEC with that in other organ carcinomas needs further mechanism researches.Entities:
Keywords: Endometrioid endometrial carcinoma; Invasion; MALAT1; miR-200c
Mesh:
Substances:
Year: 2016 PMID: 27693631 DOI: 10.1016/j.canlet.2016.09.019
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679